Literature DB >> 3288812

Postoperative radiation as adjuvant treatment for carcinoma of the oral cavity, larynx, and pharynx: preliminary report of a prospective randomized trial.

W A Kokal1, J P Neifeld, D Eisert, J A Lipsett, W Lawrence, J D Beatty, G A Parker, R D Pezner, D U Riihimaki, J J Terz.   

Abstract

A prospective randomized trial was performed in patients with advanced squamous cell carcinomas (SCC) of the oral cavity, larynx, and pharynx to examine the effect of adjuvant postoperative radiation therapy on locoregional recurrence and survival following "curative" resection. Fifty-one patients with stage III or IV SCC treated from 1981 through 1984 were randomized to receive either surgery alone (n = 27) or surgery with postoperative radiation (n = 24). Five patients were excluded from the study after randomization because of ineligibility or protocol violations. Overall recurrence rates of 55.6% and 36.8% were noted in the surgery and surgery with adjuvant radiotherapy arms, respectively (p = NS). This trend towards a higher recurrence rate in the surgery only arm was in part due to the development of lymph node metastases in the contralateral, nonoperated neck. Thus far, no significant differences in either locoregional or overall survival have been noted between the two treatment arms. In this preliminary analysis, adjuvant postoperative radiotherapy does not appear to improve disease-free or overall survival.

Entities:  

Mesh:

Year:  1988        PMID: 3288812     DOI: 10.1002/jso.2930380202

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.

Authors:  Alysa Fairchild; Johannes A Langendijk; Sandra Nuyts; Christopher Scrase; Milan Tomsej; Danny Schuring; Akos Gulyban; Sunita Ghosh; Damien C Weber; Wilfried Budach
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481

2.  Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.

Authors:  Pencilla Lang; Jessika Contreras; Noah Kalman; Claire Paterson; Houda Bahig; Astrid Billfalk-Kelly; Sinead Brennan; Kathy Rock; Nancy Read; Varagur Venkatesan; Jinka Sathya; Lucas C Mendez; S Danielle MacNeil; Anthony C Nichols; Kevin Fung; Adrian Mendez; Eric Winquist; Sara Kuruvilla; Paul Stewart; Andrew Warner; Sylvia Mitchell; Julie A Theurer; David A Palma
Journal:  Radiat Oncol       Date:  2020-08-14       Impact factor: 3.481

3.  Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.

Authors:  Danielle N Margalit; Assuntina G Sacco; Jay S Cooper; John A Ridge; Richard L Bakst; Beth M Beadle; Jonathan J Beitler; Steven S Chang; Allen M Chen; Tom J Galloway; Shlomo A Koyfman; Carol Mita; Jared R Robbins; C Jillian Tsai; Minh T Truong; Sue S Yom; Farzan Siddiqui
Journal:  Head Neck       Date:  2020-10-23       Impact factor: 3.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.